International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(5), С. 2841 - 2841
Опубликована: Фев. 29, 2024
Metabolic
syndrome
(MetS)
is
a
combination
of
metabolic
disorders
that
concurrently
act
as
factors
promoting
systemic
pathologies
such
atherosclerosis
or
diabetes
mellitus.
It
now
believed
to
encompass
six
main
interacting
conditions:
visceral
fat,
imbalance
lipids
(dyslipidemia),
hypertension,
insulin
resistance
(with
without
impairing
both
glucose
tolerance
and
fasting
blood
sugar),
inflammation.
In
the
last
10
years,
there
has
been
progressive
interest
through
scientific
research
investigations
conducted
in
field
metabolomics,
confirming
trend
evaluate
role
metabolome,
particularly
intestinal
one.
The
microbiota
(IM)
crucial
due
diversity
microorganisms
their
abundance.
Consequently,
IM
dysbiosis
its
derivate
toxic
metabolites
have
correlated
with
MetS.
By
intervening
these
two
(dysbiosis
consequently
metabolome),
we
can
potentially
prevent
slow
down
clinical
effects
MetS
process.
This,
turn,
may
mitigate
dysregulations
axes,
lung
axis,
thereby
alleviating
negative
impact
on
respiratory
pathology,
chronic
obstructive
pulmonary
disease.
However,
biomolecular
mechanisms
which
influences
host’s
metabolism
via
metabolome
normal
pathological
conditions
are
still
unclear.
this
study,
seek
provide
description
knowledge
date
influence
it.
Furthermore,
analyze
interactions
between
functions
pathophysiology
major
diseases
local
metabolome’s
relate
endotoxemia.
Internal and Emergency Medicine,
Год журнала:
2023,
Номер
19(2), С. 275 - 293
Опубликована: Июль 28, 2023
Abstract
The
intestine
is
the
largest
interface
between
internal
body
and
external
environment.
intestinal
barrier
a
dynamic
system
influenced
by
composition
of
microbiome
activity
intercellular
connections,
regulated
hormones,
dietary
components,
inflammatory
mediators,
enteric
nervous
(ENS).
Over
years,
it
has
become
increasingly
evident
that
maintaining
stable
crucial
to
prevent
various
potentially
harmful
substances
pathogens
from
entering
Disruption
referred
as
'leaky
gut'
or
leaky
gut
wall
syndrome
seems
be
characterized
release
bacterial
metabolites
endotoxins,
such
lipopolysaccharide
(LPS),
into
circulation.
This
condition,
mainly
caused
infections,
oxidative
stress,
high-fat
diet,
exposure
alcohol
chronic
allergens,
dysbiosis,
appear
highly
connected
with
development
and/or
progression
several
metabolic
autoimmune
systemic
diseases,
including
obesity,
non-alcoholic
fatty
liver
disease
(NAFLD),
neurodegeneration,
cardiovascular
disease,
bowel
type
1
diabetes
mellitus
(T1D).
In
this
review,
starting
description
mechanisms
enable
homeostasis
analyzing
relationship
complex
ecosystem
pathological
conditions,
we
explore
role
in
driving
inflammation,
also
shedding
light
on
current
future
therapeutic
interventions.
Frontiers in Cellular and Infection Microbiology,
Год журнала:
2022,
Номер
12
Опубликована: Ноя. 8, 2022
The
incidence
of
nonalcoholic
fatty
liver
disease
(NAFLD)
is
increasing
recently
and
has
become
one
the
most
common
clinical
diseases.
Since
pathogenesis
NAFLD
not
been
completely
elucidated,
few
effective
therapeutic
drugs
are
available.
As
“second
genome”
human
body,
gut
microbiota
plays
an
important
role
in
digestion,
absorption
metabolism
food
drugs.
Gut
can
act
as
driver
to
advance
occurrence
development
NAFLD,
accelerate
its
progression
cirrhosis
hepatocellular
carcinoma.
Growing
evidence
demonstrated
that
metabolites
directly
affect
intestinal
morphology
immune
response,
resulting
abnormal
activation
inflammation
endotoxemia;
dysbiosis
also
causes
dysfunction
gut-liver
axis
via
alteration
bile
acid
pathway.
Because
composition
diversity
disease-specific
expression
characteristics,
holds
strong
promise
novel
biomarkers
targets
for
NAFLD.
Intervening
microbiota,
such
antibiotic/probiotic
treatment
fecal
transplantation,
a
strategy
preventing
treating
In
this
article,
we
have
reviewed
emerging
functions
association
bacterial
components
different
stages
discussed
potential
implications
diagnosis
therapy.
Milk-derived
extracellular
vesicles
(mEVs)
have
been
proposed
as
a
potential
nanomedicine
for
intestinal
disorders;
however,
their
impact
on
barrier
integrity
in
gut
inflammation
and
associated
metabolic
diseases
has
not
explored
yet.
Here,
mEVs
derived
from
bovine
human
breast
milk
exert
similar
protective
effects
epithelial
tight
junction
functionality
vitro,
survive
harsh
gastrointestinal
conditions
ex
vivo,
reach
the
colon
vivo.
Oral
administration
of
restores
at
multiple
levels,
including
mucus,
epithelial,
immune
barriers,
prevents
endotoxin
translocation
into
liver
chemical-induced
experimental
colitis
diet-induced
nonalcoholic
steatohepatitis
(NASH),
thereby
alleviating
disorders,
inflammation,
NASH.
treatment
gut-liver
axis-associated
via
protection
integrity.
Cardiovascular Research,
Год журнала:
2023,
Номер
119(9), С. 1787 - 1798
Опубликована: Июнь 26, 2023
Abstract
The
prevalence
of
non-alcoholic
fatty
liver
disease
(NAFLD)
is
continually
increasing
due
to
the
global
obesity
epidemic.
NAFLD
comprises
a
systemic
metabolic
accompanied
frequently
by
insulin
resistance
and
hepatic
inflammation.
Whereas
simple
steatosis
most
common
manifestation,
more
progressive
course
characterized
fibrosis
inflammation
(i.e.
steatohepatitis)
present
in
10–20%
affected
individuals.
furthermore
progresses
substantial
number
patients
towards
cirrhosis
hepatocellular
carcinoma.
this
now
affects
almost
25%
world’s
population
mainly
observed
type
2
diabetes,
also
lean
Pathophysiology
involves
lipotoxicity,
immune
disturbances
resistance,
gut
dysbiosis,
commonly
defining
disorder
prototypic
disorder.
Not
surprisingly
many
have
other
manifestations,
indeed
cardiovascular
disease,
chronic
kidney
extrahepatic
malignancies
are
all
contributing
substantially
patient
outcome.
Weight
loss
lifestyle
change
reflect
cornerstone
treatment,
several
medical
treatment
options
currently
under
investigation.
promising
strategies
include
glucagon-like
peptide
1
receptor
antagonists,
sodium–glucose
transporter
inhibitors,
Fibroblast
Growth
Factor
analogues,
Farnesoid
X
agonists,
peroxisome
proliferator–activated
agonists.
Here,
we
review
epidemiology,
pathophysiology,
therapeutic
for
NAFLD.
Journal of Translational Medicine,
Год журнала:
2023,
Номер
21(1)
Опубликована: Май 4, 2023
Abstract
Alcoholism
is
a
widespread
and
damaging
behaviour
of
people
throughout
the
world.
Long-term
alcohol
consumption
has
resulted
in
alcoholic
liver
disease
(ALD)
being
leading
cause
chronic
disease.
Many
metabolic
enzymes,
including
dehydrogenases
such
as
ADH,
CYP2E1,
CATacetaldehyde
ALDHsand
nonoxidative
metabolizing
enzymes
SULT,
UGT,
FAEES,
are
involved
metabolism
ethanol,
main
component
beverages.
Ethanol
changes
functional
or
expression
profiles
various
regulatory
factors,
kinases,
transcription
microRNAs.
Therefore,
underlying
mechanisms
ALD
complex,
involving
inflammation,
mitochondrial
damage,
endoplasmic
reticulum
stress,
nitrification,
oxidative
stress.
Moreover,
recent
evidence
demonstrated
that
gut-liver
axis
plays
critical
role
pathogenesis.
For
example,
ethanol
damages
intestinal
barrier,
resulting
release
endotoxins
alterations
flora
content
bile
acid
metabolism.
However,
therapies
show
low
effectiveness.
this
review
summarizes
pathways
highly
influential
pathogenic
factors
pathology
with
aim
new
therapeutic
insights.
Frontiers in Endocrinology,
Год журнала:
2025,
Номер
15
Опубликована: Янв. 17, 2025
Obesity
is
a
major
modifiable
risk
factor
leading
to
neuroinflammation
and
neurodegeneration.
Excessive
fat
storage
in
obesity
promotes
the
progressive
infiltration
of
immune
cells
into
adipose
tissue,
resulting
release
pro-inflammatory
factors
such
as
cytokines
adipokines.
These
inflammatory
mediators
circulate
through
bloodstream,
propagating
inflammation
both
periphery
central
nervous
system.
Gut
dysbiosis,
which
results
leaky
intestinal
barrier,
exacerbates
plays
significant
role
linking
pathogenesis
neurodegeneration
gut-brain/gut-brain-liver
axis.
Inflammatory
states
within
brain
can
lead
insulin
resistance,
mitochondrial
dysfunction,
autolysosomal
increased
oxidative
stress.
disruptions
impair
normal
neuronal
function
subsequently
cognitive
decline
motor
deficits,
similar
pathologies
observed
neurodegenerative
diseases,
including
Alzheimer's
disease,
multiple
sclerosis,
Parkinson's
disease.
Understanding
underlying
disease
mechanisms
crucial
for
developing
therapeutic
strategies
address
defects
these
metabolic
pathways.
In
this
review,
we
summarize
provide
insights
different
strategies,
methods
alter
gut
lifestyle
changes,
dietary
supplementation,
well
pharmacological
agents
derived
from
natural
sources,
that
target
obesity-induced
International Journal of Molecular Sciences,
Год журнала:
2025,
Номер
26(7), С. 3148 - 3148
Опубликована: Март 28, 2025
Oxidative
stress
(OS)
and
gut
microbiota
are
crucial
factors
influencing
human
health,
each
playing
a
significant
role
in
the
development
progression
of
chronic
diseases.
This
review
provides
comprehensive
analysis
complex
interplay
between
these
two
factors,
focusing
on
how
an
imbalance
reactive
oxygen
species
(ROS)
antioxidants
leads
to
OS,
disrupting
cellular
homeostasis
contributing
range
conditions,
including
metabolic
disorders,
cardiovascular
diseases,
neurological
cancer.
The
microbiota,
diverse
community
microorganisms
residing
gastrointestinal
tract,
is
essential
for
regulating
immune
responses,
pathways,
overall
health.
Dysbiosis,
composition,
closely
associated
with
inflammation,
dysfunction,
various
highlights
influences
influenced
by
complicating
pathophysiology
many
conditions.
Furthermore,
emerging
evidence
has
identified
extracellular
vesicles
(EVs)
as
critical
facilitators
crosstalk
OS
microbiota.
EVs
also
play
signaling
host
tissues,
modulating
processes.
function
holds
promise
targeted
therapies
aimed
at
restoring
microbial
balance
mitigating
OS.
Personalized
therapeutic
approaches,
probiotics,
antioxidants,
fecal
transplantation-based
strategies,
can
be
used
address
OS-related
diseases
improve
health
outcomes.
Nonetheless,
further
research
needed
study
molecular
mechanisms
underlying
interactions
potential
innovative
interventions
offer
novel
strategies
managing
enhancing
Cells,
Год журнала:
2021,
Номер
10(12), С. 3306 - 3306
Опубликована: Ноя. 25, 2021
Non-alcoholic
fatty
liver
disease
(NAFLD)
is
a
global
clinical
problem.
The
MD2-TLR4
pathway
exacerbates
NAFLD
progression
by
promoting
inflammation.
Long-term
exercise
considered
to
improve
but
the
underlying
mechanism
still
unclear.
In
this
study,
we
examined
protective
effect
and
molecular
of
on
high-fat
diet
(HFD)-induced
injury.
an
HFD-induced
mouse
model,
training
significantly
decreased
hepatic
steatosis
fibrosis.
Interestingly,
blocked
binding
downstream
inflammatory
response.
Irisin
myokine
that
highly
expressed
in
response
exerts
anti-inflammatory
effects.
We
found
circulating
irisin
levels
muscle
expression
were
increased
exercised
mice,
suggesting
could
mediate
NAFLD.
vitro
studies
showed
improved
lipid
metabolism,
fibrosis,
inflammation
palmitic
acid
(PA)-stimulated
AML12
cells.
Moreover,
assay
results
disturbed
complex
formation
directly
with
MD2
not
TLR4,
interfered
recognition
stimuli
such
as
PA
lipopolysaccharide
MD2.
Our
study
provides
novel
evidence
exercise-induced
inhibits
via
competitive
Thus,
be
potential
therapy
for
Journal of Gastrointestinal Surgery,
Год журнала:
2023,
Номер
27(7), С. 1466 - 1472
Опубликована: Март 27, 2023
Inflammation
is
known
to
be
an
essential
driver
of
various
types
cancer.
An
increasing
number
studies
have
suggested
that
the
occurrence
and
development
colorectal
cancer
(CRC)
are
linked
inflammatory
microenvironment
intestine.
This
assumption
further
supported
by
fact
patients
with
bowel
disease
(IBD)
more
likely
develop
CRC.
Multiple
in
mice
humans
shown
preoperative
systemic
response
predictive
recurrence
after
potentially
curative
resection.
Lipopolysaccharides
(LPS)
membrane
surface
markers
gram-negative
bacteria,
which
induce
gut
barrier
dysfunction
inflammation
might
significantly
involved
A
selective
literature
search
was
conducted
Medline
PubMed,
using
terms
"Colorectal
Cancer",
"Gut
Barrier",
"Lipopolysaccharides",
"Inflammation".
Disruption
intestinal
homeostasis,
including
dysfunction,
increased
LPS
levels
a
critical
factor
for
chronic
inflammation.
can
activate
diverse
nuclear
factor-κB
(NF-κB)
pathway
via
Toll-like
receptors
4
(TLR4)
promote
response,
aggravates
encourages
CRC
development.
intact
prevents
antigens
bacteria
from
crossing
endothelial
layer
entering
circulation.
In
contrast,
damaged
triggers
responses
increases
susceptibility
Thus,
targeting
promising
novel
therapeutic
approach
additional
treatment
Gut
dysfuction
bacterial
seem
play
important
role
pathogenesis
progression
therefore
require
investigation.